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Streptococcus suis (S. suis) is an important pathogen of pigs and con-
sidered to be responsible for various diseases such as septicemia with 
sudden death, meningitis, endocarditits, and arthritis (Gottschalk, 
Segura, & Xu, 2007). Currently, there are at least 29 S. suis serotypes 
(Okura et al., 2016) described based on a serological reaction against 
the capsular polysaccharide (CPS), which has been described to be 
a major virulence factor with antiphagocytic properties (Baums & 
Valentin-Weigand, 2009). S. suis serotype 14 and in particular heterog-
enous serotype 2 are emerging zoonotic pathogens often associated 
with disease in both pigs and humans worldwide (Goyette-Desjardins, 
Auger, Xu, Segura, & Gottschalk, 2014). Formerly, serological typing 
was performed with different antisera of known type, based on three 
different techniques: Neufeld's capsular reaction, capillary precip-
itation, and coagglutination tests (Gottschalk, Higgins, Jacques, & 
Dubreuil, 1992). In recent times, more frequently multiplex PCR as-
says are used targeting genes based on CPS (Okura et al., 2014), which 
are identical for serotype pairs 2 and 1/2, and 1 and 14 except for a 
single base pair substitution in codon 161 of cpsK gene (Athey et al., 
2016). A challenge for diagnostic laboratories is the fact that available 
PCR tests do not allow resolving these aforementioned serotype pairs 
2 and 1/2, and 1 and 14.
Recently, an in silico pipeline using whole-genome sequencing 
(WGS) short-read data was developed, which is able to differentiate 
these serotypes (Athey et al., 2016). Nevertheless, for a rapid iden-
tification of potential zoonotic strains with serotypes 2 and 14, a 
reliable inexpensive and feasible high-throughput approach for rou-
tine diagnostic laboratories would be a valuable tool. The aim of this 
study was to evaluate the potential of cpsK as target for differentiat-
ing S. suis serotypes 2, 1/2, 1, and 14 from pure culture using a novel 
high resolution melting (HRM) assay.
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This rapid high resolution melting (HRM) assay allows distinguishing between 
Streptococcus suis serotype pairs 2 and 1/2 as well as 1 and 14, respectively, based 
on a single-nucleotide polymorphism within capsular polysaccharide synthesis gene 
cluster K. This assay is easy to implement and identifies potential zoonotic serotypes.
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2  | MATERIAL S AND METHODS
For this purpose, four reference strains comprising serotypes 2, 
1/2, 1, and 14, one human, and 12 porcine S. suis isolates of se-
rotypes 1 or 14 and 2 or 1/2 were used to develop a novel HRM 
assay (Table 1). Moreover, 58 S. suis isolates of other serotypes, 
as well as four further Streptococcus spp. isolates were included 
in the study. All strains were grown on Columbia agar with sheep 
blood (Thermo Fisher Diagnostics AG) and incubated at 37°C 
for 48 hr under aerobic conditions. Strains were identified by 
matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF MS, Bruker). Genomic DNA was ex-
tracted using a standard heat lysis protocol (Sambrook & Russel, 
2006).
The cpsK region flanking the nonsynonymous single-nucle-
otide polymorphism (SNP) at base pair position 483 (Athey et 
al., 2016; Roy et al., 2017) (G for serotypes 2 and 14, T or C for 
serotypes 1 and 1/2) was targeted using the following primers: 
(cpsK_for:	 5′-	 GATGGTCATCGCTTTGTGGTG-3′)	 and	 (cpsK_rev:	
5′-	GAGCAAGCGATAAGTGAAGTATTCATC-3′)	 and	producing	an	
TA B L E  1   Bacterial strains used for HRM development
Strains Strain designation Source Year of isolation Serotypea Definitive Serotypeb
Sequence 
typec (ST)
S. suis ZH 468 Mitral valve/pigd 2007 2 or 1/2 1/2 ST28
S. suis ZH 1192 Lung/pigd 2015 2 or 1/2 1/2 ST28
S. suis ZH 423 Heart/pigd 2016 2 or 1/2 1/2 ST1133
S. suis ZH 1329 Brain/pigd 2015 2 or 1/2 2 ST1103
S. suis ZH 462 Heart/pigd 2016 2 or 1/2 2 ST28
S. suis ZH 269 Heart/pigd 2015 1 or 14 1 ST13
S. suis ZH 1598 Brain/pigd 2016 1 or 14 1 ST13
S. suis ZH 1635 Joint/pigd 2017 1 or 14 1 ST13
S. suis ZH 1656 Joint/pigd 2017 1 or 14 1 ST13
S. suis ZH 730 Joint/pigd 2018 1 or 14 1 ST13
S. suis ZH 735 Joint/pigd 2018 1 or 14 1 ST13
S. suis ZH 731 Heart/pigd 2018 1 or 14 1 ST13
S. suis S. suis14 Blood/humane 2018 1 or 14 14 ST1
S. suis Ref. Serotype 1 Blood/pigf  1 1 ST13
S. suis Ref. Serotype 2 Brain/pigf  2 2 ST1
S. suis Ref. Serotype 1/2 Tonsil/pigf  1/2 1/2 ST56
S. suis Ref. Serotype 14 Not known/humanf  14 14 ST6
58 S. suis — Various tissues/pigd 2007–2017 13 different 
serotypesg
— 29 different 
ST
4 S. spp. — Various tissues/pigd 2007–2012 — — —
aSerotype characterization by multiplex PCR (Kerdsin et al., 2014). 
bDefinitive serotype assignment after S. suis HRM. 
cSequence type characterization by multilocus sequence typing (King et al., 2002). 
dStrains isolated between 2007 and 2018 from the Department of Veterinary Bacteriology, University of Zurich, Switzerland. 
eBacteriology Laboratory, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland. 
fReference strains from Swine and Poultry Infectious Diseases Research Center, Groupe de recherche sur les maladies infectieuses des animaux de 
production, University of Montreal, Saint-Hyacinthe, Canada. 
gSerotypes 3, 4, 5, 6, 7, 8, 9, 12, 15, 16, 21, 28, and 31 (belonging to 29 different sequence types) were tested. 
F I G U R E  1   Representation of sequence alignment of the cpsK amplicon generated by the HRM-PCR using primers cpsK_for and cpsK_rev 
(illustrated as pink arrows) of serotypes 2, 14, 1, and 1/2. Single-nucleotide polymorphism (SNP) region is highlighted in red, whereas 
conserved nucleotides are shown in blue. The SNP indicated gives rise to different melting behavior in the HRM assay. Accession numbers of 
GenBank of corresponding sequences are indicated
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amplicon of 117 bp (Figure 1). All qPCR experiments with subse-
quent HRM analysis were performed on a Rotor-Gene Q (Qiagen, 
Hilden, Germany) using Type-it HRM PCR Kit (Qiagen). The total 
reaction volume was 15 µl. About 1 µl of sample DNA of 100 pg 
was added to a reaction mixture containing 7.5 µl 2× Type-it HRM 
Mastermix, 0.5 µM of each primer and ultrapure water. The PCR 
thermocycling conditions were as follows: initial denaturation at 
95°C for 5 min, 40 cycles with denaturation at 95°C for 10 s, and 
annealing/extension at 66°C for 30 s followed by a second cycling 
step at 95°C for 10 s and 40°C for 2 min. Finally, a HRM ramping 
from 70°C to 82°C was performed. Fluorescence data were ac-
quired at 0.1°C increments every 2 s to generate specific melting 
curves. Reference strains with serotypes 2, 1/2, 1, and 14 were 
included as melting curve standards and positive controls. To 
exclude contaminations in the reaction mixture, ultrapure water 
was used as a negative control in each experiment. Data analy-
sis was performed using Rotor-Gene Q Software 2.3.1 (Qiagen). 
Normalized and difference plots were generated. To normalize the 
results, the premelt and postmelt signals of all samples were set 
to uniform relative values from 100% to 0%. In order to generate 
difference plots, normalized fluorescence data of sample curves 
were subtracted from the curve of reference strain serotype 1/2 
to visually accentuate differences in a greater resolution.
The HRM assay was evaluated, and its specificity was deter-
mined. To examine the intra- and interassay variability of the melting 
temperatures (Tm), representing the repeatability of the developed 
HRM assay, all isolates were tested. The variability assays were per-
formed in triplicates in three independent runs at three different 
days.
3  | RESULTS
The HRM assay clearly divided the 17 S. suis strains into two clusters 
grouping serotype 2 with 14 and serotype 1/2 with 1 (Figure 2). By 
combining serotype determination obtained by PCR (Kerdsin et al., 
2014) into serotype pairs 2 and 1/2 or serotype pairs 1 and 14 with 
the obtained results of the HRM assay, it is possible to separate and 
F I G U R E  2   Representation of a high resolution melting (HRM) assay of 12 Swiss porcine Streptococcus suis strains, one human S. suis 
strain of serotype 14, and four reference strains with serotypes 14, 2, 1, and 1/2 obtained by triplicate-testing of each strain for intra-
assay variability determination. The two groups of melting curves obtained allow rapid identification of human pathogenic S. suis serotypes 
(serotypes 2 and 14). Serotype 1/2 (red), serotype 14 (blue), serotype 1 (green), and serotype 2 (pink) are illustrated in each plot. (a) qPCR 
amplification plot; (b) melting curves of the HRM step; (c) normalized plot; (d) difference plot in relation to reference strain serotype 1/2
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correctly assign the corresponding serotype to each S. suis isolate. 
Based on our results, the target was 100% specific for the four sero-
types tested as none of the Streptococcus spp. or S. suis with differ-
ent serotypes (Table 1) yielded a PCR positive result. The intra-assay 
coefficients of variability (CVs) of Tm were between 0.008% and 
0.03% and interassay CVs, respectively, between 0.04% and 0.07% 
illustrating a highly reproducible and stable assay. Serotypes 1 and 
1/2 yielded a T
m
 of 75.9 ± 0.1°C, whereas serotypes 2 and 14 yielded 
a Tm of 76.2 ± 0.1°C, respectively (Figure 1).
4  | DISCUSSION
In this report, a novel HRM assay based on SNP detection in PCR 
products is described. HRM analysis is a rapid and low cost geno-
typing method simply convertible in laboratories as a singleplex 
method with a low risk of contamination (Reed, Kent, & Wittwer, 
2007). The reliable distinction between serotypes 2, 14, 1, and 1/2 
is useful for classification of circulating S. suis strains and helps 
strain tracking in case of disease outbreaks. In addition, this assay 
provides an easily applicable diagnostic tool for high-throughput 
screening and rapid identification of S. suis serotypes 2 and 14 rel-
evant for human infection without the need of a WGS approach. 
Compared with Sanger sequencing and WGS, a HRM assay is not 
depended on manual inspection of the sequencing data and results 
are obtained straightforward in less than 1.5 hr. Reagent costs 
are low with about 1 CHF per sample in comparison to Sanger se-
quencing, which was around ten times as expensive with an esti-
mated prize of 10 CHF per sample. The cost of WGS sequencing of 
approximately 200 CHF per sample is not competitive if the focus 
of investigation is set at serotype differentiation or at screening of 
potentially zoonotic isolates. Even though, the local reagents and 
labor cost may be variable, HRM is by far the most cost efficient 
and easily applicable assay delivering accurate results in a short 
turnaround time. Thus, a possible surveillance system contribut-
ing to the development of proficient public health policies can be 
established.
5  | CONCLUSION
To conclude, we have developed a specific HRM assay distinguish-
ing between serotype pairs 2 and 1/2 and 1 and 14, respectively, 
based on a SNP within cpsK. This assay allows a rapid separation of 
these S. suis serotypes in routine diagnostic laboratories using mo-
lecular based serotyping in order to assess a zoonotic risk of emerg-
ing strains.
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